• OPEN AN ACCOUNT
Indian Indices
Sensex
78,009.25 -70.71
( -0.09%)
Global Indices
Nasdaq
53,757.60 -103.39
(-0.19%)
Dow Jones
7,807.18 -12.81
(-0.16%)
Hang Seng
68,711.00 402.41
(0.59%)
Nikkei 225
10,753.31 -19.36
(-0.18%)
Forex
USD-INR
95.39 0.02
(0.02%)
EUR-INR
109.98 -0.03
(-0.03%)
GBP-INR
128.68 -0.13
(-0.10%)
JPY-INR
0.60 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Focus Business Solution Ltd
Industry :  Miscellaneous
BSE Code
ISIN Demat
Book Value()
543312
INE0DXR01010
11.2350551
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
166.67
145.74
EPS(TTM)
Face Value()
Div & Yield %
1.2
10
0
 

ushdev international ltd
Kilitch Drugs (India) consolidated net profit rises 39.62% in the March 2026 quarter
May 16,2026
Net profit of Kilitch Drugs (India) rose 39.62% to Rs 14.52 crore in the quarter ended March 2026 as against Rs 10.40 crore during the previous quarter ended March 2025. Sales rose 46.33% to Rs 89.60 crore in the quarter ended March 2026 as against Rs 61.23 crore during the previous quarter ended March 2025.

For the full year,net profit rose 13.00% to Rs 30.17 crore in the year ended March 2026 as against Rs 26.70 crore during the previous year ended March 2025. Sales rose 18.73% to Rs 235.47 crore in the year ended March 2026 as against Rs 198.32 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales89.6061.23 46 235.47198.32 19
OPM %24.7223.83 -15.5415.87 -
PBDT21.1914.69 44 42.2837.58 13
PBT20.2113.84 46 38.6534.47 12
NP14.5210.40 40 30.1726.70 13